We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Reneo Pharmaceuticals

News List

Reneo Receives FDA Orphan Drug Designation for Primary Mitochondrial Myopathies Treatment americanpharmaceuticalreview
July 03, 2020
Reneo Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development has granted Orphan Drug Designation to the company's lead drug candidate, REN001, for the treatment of primary mitochondrial myopathies ...
Reneo Pharmaceuticals Initiates Clinical Trial in McArdle Disease americanpharmaceuticalreview
March 09, 2020
Reneo Pharmaceuticals has expanded its clinical development program for REN001, into glycogen storage disease type V (GSD V), also known as McArdle disease.